Your browser doesn't support javascript.
loading
Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer cells.
Katoch, Archana; Jamwal, Vijay Lakshmi; Faheem, Mir Mohd; Kumar, Sriram; Senapati, Shantibhusan; Yadav, Govind; Gandhi, Sumit G; Goswami, Anindya.
Afiliación
  • Katoch A; Academy of Scientific & Innovative Research (AcSIR), New Delhi, India; Cancer Pharmacology Division, Indian Institute of Integrative Medicine (CSIR), Canal Road, Jammu, Jammu and Kashmir 180001, India.
  • Jamwal VL; Academy of Scientific & Innovative Research (AcSIR), New Delhi, India; Plant Biotechnology and System Biology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
  • Faheem MM; Cancer Pharmacology Division, Indian Institute of Integrative Medicine (CSIR), Canal Road, Jammu, Jammu and Kashmir 180001, India.
  • Kumar S; Department of Biotechnology, Rajalakshmi Engineering College (Anna University), Rajalakshmi Nagar, Thandalam, Chennai 602105, Tamil Nadu, India.
  • Senapati S; Tumor Microenvironment and Animal Models Lab, Institute of Life Sciences (ILS), Nalco Square Bhubaneswar, Orissa 751023, India.
  • Yadav G; Central Laboratory Animal Facility (Animal House), CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
  • Gandhi SG; Academy of Scientific & Innovative Research (AcSIR), New Delhi, India; Plant Biotechnology and System Biology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India. Electronic address: sumit@iiim.ac.in.
  • Goswami A; Academy of Scientific & Innovative Research (AcSIR), New Delhi, India; Cancer Pharmacology Division, Indian Institute of Integrative Medicine (CSIR), Canal Road, Jammu, Jammu and Kashmir 180001, India. Electronic address: agoswami@iiim.ac.in.
Transl Oncol ; 14(1): 100879, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33045679
The last decade has witnessed a substantial expansion in the field of microRNA (miRNA) biology, providing crucial insights into the role of miRNAs in disease pathology, predominantly in cancer progression and its metastatic spread. The discovery of tumor-suppressing miRNAs represents a potential approach for developing novel therapeutics. In this context, through miRNA microarray analysis, we examined the consequences of Prostate apoptosis response-4 (Par-4), a well-established tumor-suppressor, stimulation on expression of different miRNAs in Panc-1 cells. The results strikingly indicated elevated miR-200c levels in these cells upon Par-4 overexpression. Intriguingly, the Reverse Phase Protein Array (RPPA) analysis revealed differentially expressed proteins (DEPs), which overlap between miR200c- and Par-4-transfected cells, highlighting the cross-talks between these pathways. Notably, Phospho-p44/42 MAPK; Bim; Bcl-xL; Rb Phospho-Ser807, Ser811; Akt Phospho-Ser473; Smad1/5 Phospho-Ser463/Ser465 and Zyxin scored the most significant DEPs among the two data sets. Furthermore, the GFP-Par-4-transfected cells depicted an impeded expression of critical mesenchymal markers viz. TGF-ß1, TGF-ß2, ZEB-1, and Twist-1, concomitant with augmented miR-200c and E-cadherin levels. Strikingly, while Par-4 overexpression halted ZEB-1 at the transcriptional level; contrarily, silencing of endogenous Par-4 by siRNA robustly augmented the Epithelial-mesenchymal transition (EMT) markers, along with declining miR-200c levels. The pharmacological Par-4-inducer, NGD16, triggered Par-4 expression which corresponded with increased miR-200c resulting in the ZEB-1 downregulation. Noteworthily, tumor samples obtained from the syngenic mouse pancreatic cancer model revealed elevated miR-200c levels in the NGD16-treated mice that positively correlated with the Par-4 and E-cadherin levels in vivo; while a negative correlation was evident with ZEB-1 and Vimentin.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Transl Oncol Año: 2021 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Transl Oncol Año: 2021 Tipo del documento: Article País de afiliación: India